Investors

SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045418.rtf View HTML 0001209191-23-045418.pdf 0001209191-23-045418.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045430.rtf View HTML 0001209191-23-045430.pdf 0001209191-23-045430.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045429.rtf View HTML 0001209191-23-045429.pdf 0001209191-23-045429.xls
April 12, 2021	UPLOAD	UPLOAD	Other	0000000000-21-004381.rtf View HTML 0000000000-21-004381.pdf
August 04, 2020	UPLOAD	UPLOAD	Other	0000000000-20-007103.rtf View HTML 0000000000-20-007103.pdf
February 10, 2015	UPLOAD	UPLOAD	Other	View HTML 0000000000-15-008383.pdf
January 15, 2015	UPLOAD	UPLOAD	Other	View HTML 0000000000-15-002258.pdf
August 10, 2017	UPLOAD	UPLOAD	Other	View HTML 0000000000-17-028199.pdf
July 26, 2017	UPLOAD	UPLOAD	Other	View HTML 0000000000-17-026184.pdf
March 17, 2015	UPLOAD	UPLOAD	Other	View HTML 0000000000-15-015743.pdf

Data provided by Kaleidoscope.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert
Report Alert

Click here to unsubscribe from email alerts

© 2024 Chinook Therapeutics, Inc.. All rights reserved

Website Design: Hane Chow, Inc.